Cardiac magnetic resonance T2 mapping and feature tracking in athlete's heart and HCM

Mareike Gastl1, Vera Lachmann2, Aikaterini Christidi2

  • 1Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich Heine University Düsseldorf, Moorenstraße 5, Düsseldorf, 40225, Germany. Mareike.Cramer@med.uni-duesseldorf.de.

European Radiology
|October 16, 2020
PubMed

Insights

Cardiovascular magnetic resonance (CMR) with T2 mapping and deformation imaging can differentiate hypertrophic cardiomyopathy (HCM) from athlete's heart (AH). These advanced imaging techniques help distinguish pathological left ventricular hypertrophy (LVH) in athletes for better risk assessment.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Sports Medicine

Background:

  • Distinguishing hypertrophic cardiomyopathy (HCM) from athlete's heart (AH), a form of left ventricular hypertrophy (LVH) due to training, is challenging based on morphology alone.
  • Accurate differentiation is crucial for risk assessment in competitive athletes.

Purpose of the Study:

  • To evaluate the utility of T2 mapping and deformation imaging via cardiovascular magnetic resonance (CMR) in differentiating AH from HCM (both obstructive and non-obstructive).

Main Methods:

  • CMR including T2 mapping and strain analysis (global longitudinal strain - GLS) was performed on patients with HCM (HOCM/HNCM) and strength-trained athletes (AH).
  • Left ventricular (LV) parameters such as LV mass index (LVMi) and interventricular septum thickness (IVS) were assessed.
  • T2 values and GLS were analyzed and compared between groups.

Main Results:

  • While LVMi did not differ, interventricular septum thickness was greater in HOCM patients compared to athletes.
  • Global longitudinal strain (GLS) was significantly higher in HCM patients (HOCM/HNCM) than in athletes (AH).
  • Median T2 values were elevated in HCM patients compared to controls, but not in athletes. ROC analysis showed T2 values (AUC 0.78) and GLS (AUC 0.91) effectively discriminate AH from HCM.

Conclusions:

  • Multiparametric CMR, incorporating T2 mapping and deformation imaging, provides valuable information to distinguish athlete's heart from hypertrophic cardiomyopathy.
  • These advanced CMR techniques aid in differentiating pathological LVH from physiological changes in athletes, impacting sports participation decisions.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
229
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
8.7K
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
234
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
117
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
240